May 22, 2020
C2I Alumni, SQZ Biotechnologies, announces $65M investment to push cancer vaccine and cell-squeezing
C2I alumni, SQZ Biotechnologies, announced a $65M investment by Roche to push a cancer vaccine for HPV-positive tumors through phase 1...